XtalPi Holdings Limited (HKG:2228)

Market Cap	23.31B
Revenue (ttm)	283.53M
Net Income (ttm)	-1.61B
Shares Out	4.02B
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,580,863
Average Volume	76,973,789
Open	5.68
Previous Close	5.80
Day's Range	5.26 - 5.78
52-Week Range	3.05 - 16.20
Beta	n/a
RSI	40.74
Earnings Date	Mar 28, 2025

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled nov...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 783
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.

Financial numbers in CNY